Capua BioServices Completes Expansion of GMP Manufacturing Capabilities

In order to continuously add value to its growing customer base, Capua BioServices has designed its entire facility to be remarkably flexible; from lab - to development - to commercial production scale. This specific investment to renew this existing plant, is focused on further increasing its multi-purpose manufacturing capabilities for pharma-grade manufacturing. The strength of this new set up is that it can be used to process - via an integrated state-of-the-art modular tangential-flow-filtration system - serval thousands of litres to tens of thousands of litres in a very time- and space-efficient manner, still leaving further room for expansion.

"We are very happy that our shareholder, Livia Group, is supporting our investment in this field. There is a strong commitment from us to increasingly support the developers of advanced therapies throughout the dynamics of clinical development, while navigating towards seamless transition to commercial production," said Sabine Decker , Chief Operating Officer of Capua BioServices. "We are convinced that with this refurbishment and expansion of this installation which will house a large diversity of unit operations, we can provide a broader offer to our customers and assist them to rapidly deliver clinical candidates to patients."

Capua BioServices is a global provider of high-quality services in the field of custom microbial process development and manufacturing. Capua offers dedicated solutions for the process development and manufacturing of proteins, enzymes, antibodies/fragments and specialty compounds for applications in pharmaceutical and food markets.

As the largest, independent, beta-lactam free microbial contract manufacturing facility in Europe , it has an extensive experience in working with a variety of bacterial, yeast and fungal systems. Located near Naples , in the south of Italy , it has a total fermentation capacity of about 1400 m3 spread over two separate fermentation areas. 

Capua has dedicated areas for pharmaceutical manufacturing as well as food-grade manufacturing and complies to cGMP (FDA and EMA approved), GFSI (FSSC 22.000) and ISO standards (14001).